Skip to main navigation Skip to search Skip to main content

A role for spinal, but not supraspinal, alpha(2) adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic

  • K. Svokos
  • , J.B. Nalwalk
  • , R. Leurs
  • , W.M.P.B. Menge
  • , H. Timmerman
  • , L.H. Hough

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Improgan is a derivative of cimetidine that induces non-opioid antinociception after intracerebroventricular (i.c.v.) administration, but the mechanism of action of this compound remains unknown. Since activation of either supraspinal or spinal α
Original languageEnglish
Pages (from-to)12-9
JournalBrain Research
Volume923
Issue number1-2
DOIs
Publication statusPublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A role for spinal, but not supraspinal, alpha(2) adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic'. Together they form a unique fingerprint.

Cite this